CIK 0001178253
- Non-accelerated filer
- Smaller reporting company
SCYNEXIS INC
Sign in to watch- Ticker
- SCYX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 562181648
- Phone
- +1 201-884-5485
- Business address
- 1 EVERTRUST PLAZA, 13TH FLOOR, JERSEY CITY, NJ, 07302-6548
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 76 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-01-03 | Machado Patrick Director | Grant or award · Stock Option (right to buy) | +14,499 | 14,499 | ||
| 2017-01-03 | Macdonald Guy Director | Grant or award · Stock Option (right to buy) | +14,499 | 14,499 | ||
| 2016-12-21 | Taglietti Marco Chief Executive Officer | Purchase | +25,000 | $3.30 | $83K | 251,000 |
| 2016-12-16 | Angulo Gonzalez David Chief Medical Officer | Purchase | +4,000 | $3.25 | $13K | 46,000 |
| 2016-10-03 | GILMAN STEVEN C Director | Grant or award · Stock Option (right to buy) | +977 | 977 | ||
| 2016-10-03 | Macdonald Guy Director | Grant or award · Stock Option (right to buy) | +6,255 | 6,255 | ||
| 2016-09-15 | Machado Patrick Director | Purchase | +40,000 | $2.94 | $118K | 60,000 |
| 2016-07-01 | Macdonald Guy Director | Grant or award · Stock Option (right to buy) | +12,996 | 12,996 | ||
| 2016-07-01 | GILMAN STEVEN C Director | Grant or award · Stock Option (right to buy) | +2,030 | 2,030 | ||
| 2016-06-30 | Angulo Gonzalez David Chief Medical Officer | Purchase | +32,150 | $2.23 | $72K | 41,000 |
| 2016-06-29 | Angulo Gonzalez David Chief Medical Officer | Purchase | +4,800 | $2.18 | $10K | 8,850 |
| 2016-06-24 | Machado Clarence Patrick Director | Purchase | +20,000 | $2.39 | $48K | 20,000 |
| 2016-06-24 | Machado Clarence Patrick Director | Purchase · Common Stock Warrant (right to buy) | +9,000 | $0.02 | $180 | 9,000 |
| 2016-06-24 | Francois Eric Chief Financial Officer | Purchase | +15,000 | $2.39 | $36K | 15,000 |
| 2016-06-24 | Francois Eric Chief Financial Officer | Purchase · Common Stock Warrant (right to buy) | +6,750 | $0.02 | $135 | 6,750 |
| 2016-06-24 | Taglietti Marco Chief Executive Officer | Purchase | +100,000 | $2.39 | $239K | 225,000 |
| 2016-06-24 | Taglietti Marco Chief Executive Officer | Purchase · Common Stock Warrant (right to buy) | +45,000 | $0.02 | $900 | 45,000 |
| 2016-06-24 | Macdonald Guy Director | Purchase | +40,000 | $2.39 | $96K | 40,000 |
| 2016-06-24 | Macdonald Guy Director | Purchase · Common Stock Warrant (right to buy) | +18,000 | $0.02 | $360 | 18,000 |
| 2016-06-02 | HANHAM ANN Director | Grant or award · Stock Option (right to buy) | +8,800 | $3.98 | $35K | 8,800 |
Page 14 of 15 · 286 trades